PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.66%
Both yoy net incomes decline, with AVGO at -16.62%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-3.57%
Negative yoy D&A while AVGO is 1.66%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-100.69%
Negative yoy deferred tax while AVGO stands at 149.74%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-25.75%
Negative yoy SBC while AVGO is 31.11%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
115.01%
Well above AVGO's 0.84% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
79.44%
AR growth while AVGO is negative at -58.81%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-102.10%
Both reduce yoy inventory, with AVGO at -49.54%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
158.78%
AP growth well above AVGO's 122.19%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
97.33%
Some yoy usage while AVGO is negative at -55.52%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-100.18%
Both negative yoy, with AVGO at -16.42%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
6579.03%
Operating cash flow growth above 1.5x AVGO's 9.32%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-50.53%
Negative yoy CapEx while AVGO is 1.39%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
100.00%
Acquisition growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-58.50%
Both yoy lines negative, with AVGO at -73.68%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-12.28%
Both yoy lines are negative, with AVGO at -34.62%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-100.00%
We reduce yoy other investing while AVGO is 2940.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-344.73%
We reduce yoy invests while AVGO stands at 170.68%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
89.64%
We slightly raise equity while AVGO is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.